$2.85
-0.02-0.70%
Pre-Market: Jul 19, 7:52 PM EDT
15 minutes delayed
Comments
Loading...
Kodiak Sciences
KODNASDAQ
Kodiak Sciences (NASDAQ:KOD) Stock, Analyst Ratings, Price Targets, Forecasts
Kodiak Sciences Inc has a consensus price target of $6.38 based on the ratings of 11 analysts. The high is $15 issued by Truist Securities on August 9, 2022. The low is $2 issued by Goldman Sachs on December 11, 2023. The 3 most-recent analyst ratings were released by UBS, Barclays, and UBS on April 4, 2024, April 1, 2024, and December 21, 2023, respectively. With an average price target of $3.67 between UBS, Barclays, and UBS, there's an implied 28.65% upside for Kodiak Sciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Barclays
Goldman Sachs
Jefferies
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Kodiak Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/04/2024 | Buy Now | 75.44% | UBS | Eliana Merle | $3 → $5 | Maintains | Neutral | Get Alert |
| 04/01/2024 | Buy Now | 5.26% | Barclays | Gena Wang | $2 → $3 | Maintains | Underweight | Get Alert |
| 12/21/2023 | Buy Now | 5.26% | UBS | Eliana Merle | $4 → $3 | Maintains | Neutral | Get Alert |
| 12/11/2023 | Buy Now | -29.82% | Goldman Sachs | Andrea Tan | → $2 | Reinstates | → Sell | Get Alert |
| 11/17/2023 | Buy Now | — | Capital One | Zegbeh Jallah | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 07/27/2023 | Buy Now | 40.35% | UBS | Eliana Merle | $15 → $4 | Downgrade | Buy → Neutral | Get Alert |
| 07/25/2023 | Buy Now | — | Chardan Capital | Daniil Gataulin | — | Downgrade | Buy → Neutral | Get Alert |
| 07/25/2023 | Buy Now | -29.82% | Barclays | Gena Wang | $5 → $2 | Maintains | Underweight | Get Alert |
| 07/25/2023 | Buy Now | — | JP Morgan | Anupam Rama | — | Downgrade | Neutral → Underweight | Get Alert |
| 07/24/2023 | Buy Now | 5.26% | Jefferies | Michael Yee | → $3 | Downgrade | Buy → Hold | Get Alert |
| 07/24/2023 | Buy Now | 145.61% | Capital One | Zegbeh Jallah | → $7 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/04/2023 | Buy Now | 250.88% | JP Morgan | Anupam Rama | $12 → $10 | Maintains | Neutral | Get Alert |
| 11/14/2022 | Buy Now | 215.79% | Morgan Stanley | Matthew Harrison | $12 → $9 | Maintains | Equal-Weight | Get Alert |
| 11/10/2022 | Buy Now | 180.7% | Goldman Sachs | Graig Suvannavejh | $9 → $8 | Maintains | Neutral | Get Alert |
| 08/15/2022 | Buy Now | 321.05% | Morgan Stanley | Matthew Harrison | $10 → $12 | Maintains | Equal-Weight | Get Alert |
| 08/10/2022 | Buy Now | 531.58% | Chardan Capital | Daniil Gataulin | $19 → $18 | Maintains | Buy | Get Alert |
| 08/09/2022 | Buy Now | 426.32% | Truist Securities | Robyn Karnauskas | $10 → $15 | Maintains | Buy | Get Alert |
| 08/09/2022 | Buy Now | 215.79% | Goldman Sachs | Graig Suvannavejh | $5 → $9 | Maintains | Neutral | Get Alert |
| 08/02/2022 | Buy Now | 110.53% | Citigroup | Neena Bitritto-Garg | → $6 | Downgrade | Neutral → Sell | Get Alert |
| 05/24/2022 | Buy Now | 75.44% | Goldman Sachs | Graig Suvannavejh | $7 → $5 | Maintains | Neutral | Get Alert |
| 05/17/2022 | Buy Now | 250.88% | Morgan Stanley | Matthew Harrison | $12 → $10 | Maintains | Equal-Weight | Get Alert |
| 05/11/2022 | Buy Now | 145.61% | Goldman Sachs | Graig Suvannavejh | $8 → $7 | Maintains | Neutral | Get Alert |
| 04/12/2022 | Buy Now | 321.05% | Morgan Stanley | Matthew Harrison | $17 → $12 | Maintains | Equal-Weight | Get Alert |
| 02/24/2022 | Buy Now | 496.49% | Morgan Stanley | Matthew Harrison | $77 → $17 | Maintains | Equal-Weight | Get Alert |
| 02/24/2022 | Buy Now | 321.05% | Citigroup | Neena Bitritto-Garg | $70 → $12 | Maintains | Neutral | Get Alert |
| 02/24/2022 | Buy Now | 636.84% | JP Morgan | Anupam Rama | $90 → $21 | Downgrade | Overweight → Neutral | Get Alert |
| 02/07/2022 | Buy Now | 1654.39% | Barclays | Gena Wang | $81 → $50 | Maintains | Underweight | Get Alert |
| 02/02/2022 | Buy Now | 3057.89% | JP Morgan | Anupam Rama | → $90 | Upgrade | Neutral → Overweight | Get Alert |
| 02/01/2022 | Buy Now | 2601.75% | Morgan Stanley | Matthew Harrison | $122 → $77 | Maintains | Equal-Weight | Get Alert |
| 01/26/2022 | Buy Now | 2356.14% | Citigroup | Neena Bitritto-Garg | $114 → $70 | Maintains | Neutral | Get Alert |
| 01/18/2022 | Buy Now | 4180.7% | Morgan Stanley | Matthew Harrison | $119 → $122 | Maintains | Equal-Weight | Get Alert |
| 11/11/2021 | Buy Now | 3900% | Citigroup | Neena Bitritto-Garg | — | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Kodiak Sciences (KOD) stock?
The latest price target for Kodiak Sciences (NASDAQ:KOD) was reported by UBS on April 4, 2024. The analyst firm set a price target for $5.00 expecting KOD to rise to within 12 months (a possible 75.44% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kodiak Sciences (KOD)?
The latest analyst rating for Kodiak Sciences (NASDAQ:KOD) was provided by UBS, and Kodiak Sciences maintained their neutral rating.
When was the last upgrade for Kodiak Sciences (KOD)?
The last upgrade for Kodiak Sciences Inc happened on November 17, 2023 when Capital One raised their price target to N/A. Capital One previously had an equal-weight for Kodiak Sciences Inc.
When was the last downgrade for Kodiak Sciences (KOD)?
The last downgrade for Kodiak Sciences Inc happened on July 27, 2023 when UBS changed their price target from $15 to $4 for Kodiak Sciences Inc.
When is the next analyst rating going to be posted or updated for Kodiak Sciences (KOD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kodiak Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kodiak Sciences was filed on April 4, 2024 so you should expect the next rating to be made available sometime around April 4, 2025.
Is the Analyst Rating Kodiak Sciences (KOD) correct?
While ratings are subjective and will change, the latest Kodiak Sciences (KOD) rating was a maintained with a price target of $3.00 to $5.00. The current price Kodiak Sciences (KOD) is trading at is $2.85, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.